Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Industrial Chain
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
A-Share Information
H-Share Information
2023.08.30
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2023
2023.08.21
CHANGE OF FINANCIAL CONTROLLER
2023.08.21
ag真人平台官方：独立董事关于第六届董事会第二次会议相关事项的独立意见
2023.08.21
ag真人平台官方：关于变更财务总监的公告
2023.08.21
ag真人平台官方：第六届董事会第二次会议决议公告
2023.07.15
Profit warning
2023.07.15
ag真人平台官方：2023年半年度业绩预告
2023.07.11
ag真人平台官方：2022年年度权益分派实施公告
2023.05.23
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
2023.05.23
POLL RESULTS OF THE 2022 ANNUAL GENERAL MEETING HELD ON MAY 22, 2023
第一页
上一页
20
21
22
23
24
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Industrial Chain
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
